Global Veterinary Biological Vaccines Market Research Report 2023

Report ID: 1886061 | Published Date: Jan 2025 | No. of Page: 120 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Veterinary Biological Vaccines Market Overview
    1.1 Product Overview and Scope of Veterinary Biological Vaccines
    1.2 Veterinary Biological Vaccines Segment by Type
        1.2.1 Global Veterinary Biological Vaccines Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Live Attenuated Vaccines
        1.2.3 Inactivated Vaccines
        1.2.4 Others
    1.3 Veterinary Biological Vaccines Segment by Application
        1.3.1 Global Veterinary Biological Vaccines Sales Comparison by Application: (2022-2028)
        1.3.2 Livestock
        1.3.3 Swine
        1.3.4 Chicken
        1.3.5 Others
    1.4 Global Veterinary Biological Vaccines Market Size Estimates and Forecasts
        1.4.1 Global Veterinary Biological Vaccines Revenue 2017-2028
        1.4.2 Global Veterinary Biological Vaccines Sales 2017-2028
        1.4.3 Veterinary Biological Vaccines Market Size by Region: 2017 Versus 2021 Versus 2028
2 Veterinary Biological Vaccines Market Competition by Manufacturers
    2.1 Global Veterinary Biological Vaccines Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Veterinary Biological Vaccines Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Veterinary Biological Vaccines Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Veterinary Biological Vaccines Manufacturing Sites, Area Served, Product Type
    2.5 Veterinary Biological Vaccines Market Competitive Situation and Trends
        2.5.1 Veterinary Biological Vaccines Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Veterinary Biological Vaccines Players Market Share by Revenue
        2.5.3 Global Veterinary Biological Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Biological Vaccines Retrospective Market Scenario by Region
    3.1 Global Veterinary Biological Vaccines Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Veterinary Biological Vaccines Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Veterinary Biological Vaccines Market Facts & Figures by Country
        3.3.1 North America Veterinary Biological Vaccines Sales by Country
        3.3.2 North America Veterinary Biological Vaccines Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Veterinary Biological Vaccines Market Facts & Figures by Country
        3.4.1 Europe Veterinary Biological Vaccines Sales by Country
        3.4.2 Europe Veterinary Biological Vaccines Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Veterinary Biological Vaccines Market Facts & Figures by Region
        3.5.1 Asia Pacific Veterinary Biological Vaccines Sales by Region
        3.5.2 Asia Pacific Veterinary Biological Vaccines Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Veterinary Biological Vaccines Market Facts & Figures by Country
        3.6.1 Latin America Veterinary Biological Vaccines Sales by Country
        3.6.2 Latin America Veterinary Biological Vaccines Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
        3.6.6 Colombia
    3.7 Middle East and Africa Veterinary Biological Vaccines Market Facts & Figures by Country
        3.7.1 Middle East and Africa Veterinary Biological Vaccines Sales by Country
        3.7.2 Middle East and Africa Veterinary Biological Vaccines Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Veterinary Biological Vaccines Historic Market Analysis by Type
    4.1 Global Veterinary Biological Vaccines Sales Market Share by Type (2017-2022)
    4.2 Global Veterinary Biological Vaccines Revenue Market Share by Type (2017-2022)
    4.3 Global Veterinary Biological Vaccines Price by Type (2017-2022)
5 Global Veterinary Biological Vaccines Historic Market Analysis by Application
    5.1 Global Veterinary Biological Vaccines Sales Market Share by Application (2017-2022)
    5.2 Global Veterinary Biological Vaccines Revenue Market Share by Application (2017-2022)
    5.3 Global Veterinary Biological Vaccines Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Merck
        6.1.1 Merck Corporation Information
        6.1.2 Merck Description and Business Overview
        6.1.3 Merck Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Merck Veterinary Biological Vaccines Product Portfolio
        6.1.5 Merck Recent Developments/Updates
    6.2 Zoetis
        6.2.1 Zoetis Corporation Information
        6.2.2 Zoetis Description and Business Overview
        6.2.3 Zoetis Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Zoetis Veterinary Biological Vaccines Product Portfolio
        6.2.5 Zoetis Recent Developments/Updates
    6.3 Boehringer Ingelheim
        6.3.1 Boehringer Ingelheim Corporation Information
        6.3.2 Boehringer Ingelheim Description and Business Overview
        6.3.3 Boehringer Ingelheim Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Boehringer Ingelheim Veterinary Biological Vaccines Product Portfolio
        6.3.5 Boehringer Ingelheim Recent Developments/Updates
    6.4 Ceva
        6.4.1 Ceva Corporation Information
        6.4.2 Ceva Description and Business Overview
        6.4.3 Ceva Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Ceva Veterinary Biological Vaccines Product Portfolio
        6.4.5 Ceva Recent Developments/Updates
    6.5 CAHIC
        6.5.1 CAHIC Corporation Information
        6.5.2 CAHIC Description and Business Overview
        6.5.3 CAHIC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 CAHIC Veterinary Biological Vaccines Product Portfolio
        6.5.5 CAHIC Recent Developments/Updates
    6.6 HVRI
        6.6.1 HVRI Corporation Information
        6.6.2 HVRI Description and Business Overview
        6.6.3 HVRI Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 HVRI Veterinary Biological Vaccines Product Portfolio
        6.6.5 HVRI Recent Developments/Updates
    6.7 Yebio
        6.6.1 Yebio Corporation Information
        6.6.2 Yebio Description and Business Overview
        6.6.3 Yebio Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Yebio Veterinary Biological Vaccines Product Portfolio
        6.7.5 Yebio Recent Developments/Updates
    6.8 DHN
        6.8.1 DHN Corporation Information
        6.8.2 DHN Description and Business Overview
        6.8.3 DHN Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 DHN Veterinary Biological Vaccines Product Portfolio
        6.8.5 DHN Recent Developments/Updates
    6.9 WINSUN
        6.9.1 WINSUN Corporation Information
        6.9.2 WINSUN Description and Business Overview
        6.9.3 WINSUN Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 WINSUN Veterinary Biological Vaccines Product Portfolio
        6.9.5 WINSUN Recent Developments/Updates
    6.10 Elanco
        6.10.1 Elanco Corporation Information
        6.10.2 Elanco Description and Business Overview
        6.10.3 Elanco Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Elanco Veterinary Biological Vaccines Product Portfolio
        6.10.5 Elanco Recent Developments/Updates
    6.11 Virbac
        6.11.1 Virbac Corporation Information
        6.11.2 Virbac Veterinary Biological Vaccines Description and Business Overview
        6.11.3 Virbac Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Virbac Veterinary Biological Vaccines Product Portfolio
        6.11.5 Virbac Recent Developments/Updates
    6.12 CAVAC
        6.12.1 CAVAC Corporation Information
        6.12.2 CAVAC Veterinary Biological Vaccines Description and Business Overview
        6.12.3 CAVAC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 CAVAC Veterinary Biological Vaccines Product Portfolio
        6.12.5 CAVAC Recent Developments/Updates
    6.13 Kyoto Biken Laboratories
        6.13.1 Kyoto Biken Laboratories Corporation Information
        6.13.2 Kyoto Biken Laboratories Veterinary Biological Vaccines Description and Business Overview
        6.13.3 Kyoto Biken Laboratories Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Kyoto Biken Laboratories Veterinary Biological Vaccines Product Portfolio
        6.13.5 Kyoto Biken Laboratories Recent Developments/Updates
    6.14 FATRO
        6.14.1 FATRO Corporation Information
        6.14.2 FATRO Veterinary Biological Vaccines Description and Business Overview
        6.14.3 FATRO Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 FATRO Veterinary Biological Vaccines Product Portfolio
        6.14.5 FATRO Recent Developments/Updates
    6.15 Vaksindo
        6.15.1 Vaksindo Corporation Information
        6.15.2 Vaksindo Veterinary Biological Vaccines Description and Business Overview
        6.15.3 Vaksindo Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Vaksindo Veterinary Biological Vaccines Product Portfolio
        6.15.5 Vaksindo Recent Developments/Updates
    6.16 Bio-Labs
        6.16.1 Bio-Labs Corporation Information
        6.16.2 Bio-Labs Veterinary Biological Vaccines Description and Business Overview
        6.16.3 Bio-Labs Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 Bio-Labs Veterinary Biological Vaccines Product Portfolio
        6.16.5 Bio-Labs Recent Developments/Updates
    6.17 Avimex Animal Health
        6.17.1 Avimex Animal Health Corporation Information
        6.17.2 Avimex Animal Health Veterinary Biological Vaccines Description and Business Overview
        6.17.3 Avimex Animal Health Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Avimex Animal Health Veterinary Biological Vaccines Product Portfolio
        6.17.5 Avimex Animal Health Recent Developments/Updates
    6.18 MEVAC
        6.18.1 MEVAC Corporation Information
        6.18.2 MEVAC Veterinary Biological Vaccines Description and Business Overview
        6.18.3 MEVAC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 MEVAC Veterinary Biological Vaccines Product Portfolio
        6.18.5 MEVAC Recent Developments/Updates
    6.19 Biovac
        6.19.1 Biovac Corporation Information
        6.19.2 Biovac Veterinary Biological Vaccines Description and Business Overview
        6.19.3 Biovac Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.19.4 Biovac Veterinary Biological Vaccines Product Portfolio
        6.19.5 Biovac Recent Developments/Updates
    6.20 Atafen
        6.20.1 Atafen Corporation Information
        6.20.2 Atafen Veterinary Biological Vaccines Description and Business Overview
        6.20.3 Atafen Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.20.4 Atafen Veterinary Biological Vaccines Product Portfolio
        6.20.5 Atafen Recent Developments/Updates
    6.21 Dyntec
        6.21.1 Dyntec Corporation Information
        6.21.2 Dyntec Veterinary Biological Vaccines Description and Business Overview
        6.21.3 Dyntec Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.21.4 Dyntec Veterinary Biological Vaccines Product Portfolio
        6.21.5 Dyntec Recent Developments/Updates
    6.22 Ringpu Biology
        6.22.1 Ringpu Biology Corporation Information
        6.22.2 Ringpu Biology Veterinary Biological Vaccines Description and Business Overview
        6.22.3 Ringpu Biology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.22.4 Ringpu Biology Veterinary Biological Vaccines Product Portfolio
        6.22.5 Ringpu Biology Recent Developments/Updates
    6.23 Jinyu Bio-technology
        6.23.1 Jinyu Bio-technology Corporation Information
        6.23.2 Jinyu Bio-technology Veterinary Biological Vaccines Description and Business Overview
        6.23.3 Jinyu Bio-technology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.23.4 Jinyu Bio-technology Veterinary Biological Vaccines Product Portfolio
        6.23.5 Jinyu Bio-technology Recent Developments/Updates
    6.24 Jinhe Biotechnology
        6.24.1 Jinhe Biotechnology Corporation Information
        6.24.2 Jinhe Biotechnology Veterinary Biological Vaccines Description and Business Overview
        6.24.3 Jinhe Biotechnology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.24.4 Jinhe Biotechnology Veterinary Biological Vaccines Product Portfolio
        6.24.5 Jinhe Biotechnology Recent Developments/Updates
    6.25 China Animal Husbandry Industry
        6.25.1 China Animal Husbandry Industry Corporation Information
        6.25.2 China Animal Husbandry Industry Veterinary Biological Vaccines Description and Business Overview
        6.25.3 China Animal Husbandry Industry Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.25.4 China Animal Husbandry Industry Veterinary Biological Vaccines Product Portfolio
        6.25.5 China Animal Husbandry Industry Recent Developments/Updates
    6.26 Wuhan Keqian Biology
        6.26.1 Wuhan Keqian Biology Corporation Information
        6.26.2 Wuhan Keqian Biology Veterinary Biological Vaccines Description and Business Overview
        6.26.3 Wuhan Keqian Biology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.26.4 Wuhan Keqian Biology Veterinary Biological Vaccines Product Portfolio
        6.26.5 Wuhan Keqian Biology Recent Developments/Updates
    6.27 Pulike Biological Engineering
        6.27.1 Pulike Biological Engineering Corporation Information
        6.27.2 Pulike Biological Engineering Veterinary Biological Vaccines Description and Business Overview
        6.27.3 Pulike Biological Engineering Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.27.4 Pulike Biological Engineering Veterinary Biological Vaccines Product Portfolio
        6.27.5 Pulike Biological Engineering Recent Developments/Updates
    6.28 Chengdu Kanghua Biological Products
        6.28.1 Chengdu Kanghua Biological Products Corporation Information
        6.28.2 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Description and Business Overview
        6.28.3 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2017-2022)
        6.28.4 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product Portfolio
        6.28.5 Chengdu Kanghua Biological Products Recent Developments/Updates
7 Veterinary Biological Vaccines Manufacturing Cost Analysis
    7.1 Veterinary Biological Vaccines Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Veterinary Biological Vaccines
    7.4 Veterinary Biological Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Veterinary Biological Vaccines Distributors List
    8.3 Veterinary Biological Vaccines Customers
9 Veterinary Biological Vaccines Market Dynamics
    9.1 Veterinary Biological Vaccines Industry Trends
    9.2 Veterinary Biological Vaccines Market Drivers
    9.3 Veterinary Biological Vaccines Market Challenges
    9.4 Veterinary Biological Vaccines Market Restraints
10 Global Market Forecast
    10.1 Veterinary Biological Vaccines Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Veterinary Biological Vaccines by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Veterinary Biological Vaccines by Type (2023-2028)
    10.2 Veterinary Biological Vaccines Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Veterinary Biological Vaccines by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Veterinary Biological Vaccines by Application (2023-2028)
    10.3 Veterinary Biological Vaccines Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Veterinary Biological Vaccines by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Veterinary Biological Vaccines by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Veterinary Biological Vaccines Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Veterinary Biological Vaccines Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Veterinary Biological Vaccines Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Veterinary Biological Vaccines Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Veterinary Biological Vaccines Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Veterinary Biological Vaccines Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Veterinary Biological Vaccines Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Veterinary Biological Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Veterinary Biological Vaccines Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Veterinary Biological Vaccines Manufacturing Sites and Area Served
    Table 11. Manufacturers Veterinary Biological Vaccines Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Veterinary Biological Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Biological Vaccines as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Veterinary Biological Vaccines Sales by Region (2017-2022) & (K Units)
    Table 16. Global Veterinary Biological Vaccines Sales Market Share by Region (2017-2022)
    Table 17. Global Veterinary Biological Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Veterinary Biological Vaccines Revenue Market Share by Region (2017-2022)
    Table 19. North America Veterinary Biological Vaccines Sales by Country (2017-2022) & (K Units)
    Table 20. North America Veterinary Biological Vaccines Sales Market Share by Country (2017-2022)
    Table 21. North America Veterinary Biological Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Veterinary Biological Vaccines Revenue Market Share by Country (2017-2022)
    Table 23. Europe Veterinary Biological Vaccines Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Veterinary Biological Vaccines Sales Market Share by Country (2017-2022)
    Table 25. Europe Veterinary Biological Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Veterinary Biological Vaccines Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Veterinary Biological Vaccines Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Veterinary Biological Vaccines Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Veterinary Biological Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Veterinary Biological Vaccines Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Veterinary Biological Vaccines Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Veterinary Biological Vaccines Sales Market Share by Country (2017-2022)
    Table 33. Latin America Veterinary Biological Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Veterinary Biological Vaccines Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Veterinary Biological Vaccines Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Veterinary Biological Vaccines Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Veterinary Biological Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Veterinary Biological Vaccines Revenue Market Share by Country (2017-2022)
    Table 39. Global Veterinary Biological Vaccines Sales by Type (2017-2022) & (K Units)
    Table 40. Global Veterinary Biological Vaccines Sales Market Share by Type (2017-2022)
    Table 41. Global Veterinary Biological Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Veterinary Biological Vaccines Revenue Share by Type (2017-2022)
    Table 43. Global Veterinary Biological Vaccines Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Veterinary Biological Vaccines Sales (K Units) by Application (2017-2022)
    Table 45. Global Veterinary Biological Vaccines Sales Market Share by Application (2017-2022)
    Table 46. Global Veterinary Biological Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Veterinary Biological Vaccines Revenue Share by Application (2017-2022)
    Table 48. Global Veterinary Biological Vaccines Price by Application (2017-2022) & (US$/Unit)
    Table 49. Merck Corporation Information
    Table 50. Merck Description and Business Overview
    Table 51. Merck Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Merck Veterinary Biological Vaccines Product
    Table 53. Merck Recent Developments/Updates
    Table 54. Zoetis Corporation Information
    Table 55. Zoetis Description and Business Overview
    Table 56. Zoetis Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Zoetis Veterinary Biological Vaccines Product
    Table 58. Zoetis Recent Developments/Updates
    Table 59. Boehringer Ingelheim Corporation Information
    Table 60. Boehringer Ingelheim Description and Business Overview
    Table 61. Boehringer Ingelheim Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Boehringer Ingelheim Veterinary Biological Vaccines Product
    Table 63. Boehringer Ingelheim Recent Developments/Updates
    Table 64. Ceva Corporation Information
    Table 65. Ceva Description and Business Overview
    Table 66. Ceva Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. Ceva Veterinary Biological Vaccines Product
    Table 68. Ceva Recent Developments/Updates
    Table 69. CAHIC Corporation Information
    Table 70. CAHIC Description and Business Overview
    Table 71. CAHIC Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. CAHIC Veterinary Biological Vaccines Product
    Table 73. CAHIC Recent Developments/Updates
    Table 74. HVRI Corporation Information
    Table 75. HVRI Description and Business Overview
    Table 76. HVRI Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. HVRI Veterinary Biological Vaccines Product
    Table 78. HVRI Recent Developments/Updates
    Table 79. Yebio Corporation Information
    Table 80. Yebio Description and Business Overview
    Table 81. Yebio Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. Yebio Veterinary Biological Vaccines Product
    Table 83. Yebio Recent Developments/Updates
    Table 84. DHN Corporation Information
    Table 85. DHN Description and Business Overview
    Table 86. DHN Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. DHN Veterinary Biological Vaccines Product
    Table 88. DHN Recent Developments/Updates
    Table 89. WINSUN Corporation Information
    Table 90. WINSUN Description and Business Overview
    Table 91. WINSUN Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. WINSUN Veterinary Biological Vaccines Product
    Table 93. WINSUN Recent Developments/Updates
    Table 94. Elanco Corporation Information
    Table 95. Elanco Description and Business Overview
    Table 96. Elanco Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Elanco Veterinary Biological Vaccines Product
    Table 98. Elanco Recent Developments/Updates
    Table 99. Virbac Corporation Information
    Table 100. Virbac Description and Business Overview
    Table 101. Virbac Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Virbac Veterinary Biological Vaccines Product
    Table 103. Virbac Recent Developments/Updates
    Table 104. CAVAC Corporation Information
    Table 105. CAVAC Description and Business Overview
    Table 106. CAVAC Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. CAVAC Veterinary Biological Vaccines Product
    Table 108. CAVAC Recent Developments/Updates
    Table 109. Kyoto Biken Laboratories Corporation Information
    Table 110. Kyoto Biken Laboratories Description and Business Overview
    Table 111. Kyoto Biken Laboratories Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. Kyoto Biken Laboratories Veterinary Biological Vaccines Product
    Table 113. Kyoto Biken Laboratories Recent Developments/Updates
    Table 114. FATRO Corporation Information
    Table 115. FATRO Description and Business Overview
    Table 116. FATRO Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 117. FATRO Veterinary Biological Vaccines Product
    Table 118. FATRO Recent Developments/Updates
    Table 119. Vaksindo Corporation Information
    Table 120. Vaksindo Description and Business Overview
    Table 121. Vaksindo Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 122. Vaksindo Veterinary Biological Vaccines Product
    Table 123. Vaksindo Recent Developments/Updates
    Table 124. Bio-Labs Corporation Information
    Table 125. Bio-Labs Description and Business Overview
    Table 126. Bio-Labs Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 127. Bio-Labs Veterinary Biological Vaccines Product
    Table 128. Bio-Labs Recent Developments/Updates
    Table 129. Avimex Animal Health Corporation Information
    Table 130. Avimex Animal Health Description and Business Overview
    Table 131. Avimex Animal Health Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 132. Avimex Animal Health Veterinary Biological Vaccines Product
    Table 133. Avimex Animal Health Recent Developments/Updates
    Table 134. MEVAC Corporation Information
    Table 135. MEVAC Description and Business Overview
    Table 136. MEVAC Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 137. MEVAC Veterinary Biological Vaccines Product
    Table 138. MEVAC Recent Developments/Updates
    Table 139. Biovac Corporation Information
    Table 140. Biovac Description and Business Overview
    Table 141. Biovac Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 142. Biovac Veterinary Biological Vaccines Product
    Table 143. Biovac Recent Developments/Updates
    Table 144. Atafen Corporation Information
    Table 145. Atafen Description and Business Overview
    Table 146. Atafen Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 147. Atafen Veterinary Biological Vaccines Product
    Table 148. Atafen Recent Developments/Updates
    Table 149. Dyntec Corporation Information
    Table 150. Dyntec Description and Business Overview
    Table 151. Dyntec Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 152. Dyntec Veterinary Biological Vaccines Product
    Table 153. Dyntec Recent Developments/Updates
    Table 154. Ringpu Biology Corporation Information
    Table 155. Ringpu Biology Description and Business Overview
    Table 156. Ringpu Biology Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 157. Ringpu Biology Veterinary Biological Vaccines Product
    Table 158. Ringpu Biology Recent Developments/Updates
    Table 159. Jinyu Bio-technology Corporation Information
    Table 160. Jinyu Bio-technology Description and Business Overview
    Table 161. Jinyu Bio-technology Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 162. Jinyu Bio-technology Veterinary Biological Vaccines Product
    Table 163. Jinyu Bio-technology Recent Developments/Updates
    Table 164. Jinhe Biotechnology Corporation Information
    Table 165. Jinhe Biotechnology Description and Business Overview
    Table 166. Jinhe Biotechnology Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 167. Jinhe Biotechnology Veterinary Biological Vaccines Product
    Table 168. Jinhe Biotechnology Recent Developments/Updates
    Table 169. China Animal Husbandry Industry Corporation Information
    Table 170. China Animal Husbandry Industry Description and Business Overview
    Table 171. China Animal Husbandry Industry Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 172. China Animal Husbandry Industry Veterinary Biological Vaccines Product
    Table 173. China Animal Husbandry Industry Recent Developments/Updates
    Table 174. Wuhan Keqian Biology Corporation Information
    Table 175. Wuhan Keqian Biology Description and Business Overview
    Table 176. Wuhan Keqian Biology Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 177. Wuhan Keqian Biology Veterinary Biological Vaccines Product
    Table 178. Wuhan Keqian Biology Recent Developments/Updates
    Table 179. Pulike Biological Engineering Corporation Information
    Table 180. Pulike Biological Engineering Description and Business Overview
    Table 181. Pulike Biological Engineering Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 182. Pulike Biological Engineering Veterinary Biological Vaccines Product
    Table 183. Pulike Biological Engineering Recent Developments/Updates
    Table 184. Chengdu Kanghua Biological Products Corporation Information
    Table 185. Chengdu Kanghua Biological Products Description and Business Overview
    Table 186. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 187. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product
    Table 188. Chengdu Kanghua Biological Products Recent Developments/Updates
    Table 189. Production Base and Market Concentration Rate of Raw Material
    Table 190. Key Suppliers of Raw Materials
    Table 191. Veterinary Biological Vaccines Distributors List
    Table 192. Veterinary Biological Vaccines Customers List
    Table 193. Veterinary Biological Vaccines Market Trends
    Table 194. Veterinary Biological Vaccines Market Drivers
    Table 195. Veterinary Biological Vaccines Market Challenges
    Table 196. Veterinary Biological Vaccines Market Restraints
    Table 197. Global Veterinary Biological Vaccines Sales Forecast by Type (2023-2028) & (K Units)
    Table 198. Global Veterinary Biological Vaccines Sales Market Share Forecast by Type (2023-2028)
    Table 199. Global Veterinary Biological Vaccines Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 200. Global Veterinary Biological Vaccines Revenue Market Share Forecast by Type (2023-2028)
    Table 201. Global Veterinary Biological Vaccines Sales Forecast by Application (2023-2028) & (K Units)
    Table 202. Global Veterinary Biological Vaccines Sales Market Share Forecast by Application (2023-2028)
    Table 203. Global Veterinary Biological Vaccines Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 204. Global Veterinary Biological Vaccines Revenue Market Share Forecast by Application (2023-2028)
    Table 205. Global Veterinary Biological Vaccines Sales Forecast by Region (2023-2028) & (K Units)
    Table 206. Global Veterinary Biological Vaccines Sales Market Share Forecast by Region (2023-2028)
    Table 207. Global Veterinary Biological Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 208. Global Veterinary Biological Vaccines Revenue Market Share Forecast by Region (2023-2028)
    Table 209. Research Programs/Design for This Report
    Table 210. Key Data Information from Secondary Sources
    Table 211. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Veterinary Biological Vaccines
    Figure 2. Global Veterinary Biological Vaccines Market Share by Type in 2021 & 2028
    Figure 3. Live Attenuated Vaccines Product Picture
    Figure 4. Inactivated Vaccines Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Veterinary Biological Vaccines Market Share by Application in 2021 & 2028
    Figure 7. Livestock
    Figure 8. Swine
    Figure 9. Chicken
    Figure 10. Others
    Figure 11. Global Veterinary Biological Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Veterinary Biological Vaccines Market Size (2017-2028) & (US$ Million)
    Figure 13. Global Veterinary Biological Vaccines Sales (2017-2028) & (K Units)
    Figure 14. Veterinary Biological Vaccines Sales Share by Manufacturers in 2021
    Figure 15. Global Veterinary Biological Vaccines Revenue Share by Manufacturers in 2021
    Figure 16. The Global 5 and 10 Largest Veterinary Biological Vaccines Players: Market Share by Revenue in 2021
    Figure 17. Veterinary Biological Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global Veterinary Biological Vaccines Sales Market Share by Region (2017-2022)
    Figure 19. Global Veterinary Biological Vaccines Sales Market Share by Region in 2021
    Figure 20. Global Veterinary Biological Vaccines Revenue Market Share by Region (2017-2022)
    Figure 21. Global Veterinary Biological Vaccines Revenue Market Share by Region in 2021
    Figure 22. United States Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Canada Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Germany Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. France Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. U.K. Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Italy Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Russia Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. China Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Japan Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. South Korea Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. India Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Australia Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. China Taiwan Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Indonesia Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Thailand Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Malaysia Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Mexico Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Brazil Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Argentina Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Colombia Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Turkey Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Saudi Arabia Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. UAE Veterinary Biological Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Sales Market Share of Veterinary Biological Vaccines by Type (2017-2022)
    Figure 46. Manufacturing Cost Structure of Veterinary Biological Vaccines
    Figure 47. Manufacturing Process Analysis of Veterinary Biological Vaccines
    Figure 48. Veterinary Biological Vaccines Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Yebio
DHN
WINSUN
Elanco
Virbac
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
Ringpu Biology
Jinyu Bio-technology
Jinhe Biotechnology
China Animal Husbandry Industry
Wuhan Keqian Biology
Pulike Biological Engineering
Chengdu Kanghua Biological Products
Frequently Asked Questions
Veterinary Biological Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Veterinary Biological Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Veterinary Biological Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports